Physician profile
Michelle Liebert
NPI 1306817549
$1,042.80
in general payments reported to CMS, 2019-2025
17 companies · $85.03 in 2025
The $85.03 reported for 2025 was less than what a typical Ophthalmology provider received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $226 · 2020: $111 · 2021: $116 · 2022: $190 · 2023: $258 · 2024: $57.04 · 2025: $85.03.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $400.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $400.33 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $121.21 | 2019-2025 | Tryptyr, Clareon, Simbrinza |
| Kala Pharmaceuticals, INC. | $120.60 | 2019-2021 | |
| Santen INC. | $110.26 | 2023 | Verkazia |
| Sun Pharmaceutical Industries INC. | $108.18 | 2019-2023 | Cequa |
| Eyevance Pharmaceuticals LLC | $89.94 | 2020-2022 | |
| Tarsus Pharmaceuticals, INC. | $68.35 | 2024-2025 | Xdemvy |
| Horizon Therapeutics Plc | $67.61 | 2019-2023 | Tepezza |
| Novartis Pharmaceuticals Corporation | $58.61 | 2019-2022 | |
| Oyster Point Pharma, INC. | $54.21 | 2022 | |
| Dompe US, INC. | $50.96 | 2021-2022 | |
| Bausch & Lomb Americas INC. | $42.00 | 2022-2025 | Xiidra, Miebo |
| Biotissue Holdings INC. | $41.89 | 2019-2023 | |
| Bausch & Lomb, A Division of Bausch Health US, LLC | $33.12 | 2019-2020 | |
| Rxsight INC | $24.26 | 2023 | Rxsight Light Delivery Device (Ldd), Rxsight Injector Handpiece, Rxsight Contact Lens |
| Mallinckrodt Enterprises LLC | $18.99 | 2019 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alimera Sciences, INC. | $16.92 | 2022 | |
| Johnson & Johnson Surgical Vision, INC. | $15.69 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Michelle Liebert listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.